NCT04170413View on ClinicalTrials.gov

Feasibility of Using Contrast Enhanced Voiding Urosonography (CeVUS) During Urodynamic Studies

CompletedOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

November 2, 2020

Study Completion Date

November 2, 2020

Conditions
Neurogenic Bladder
Interventions
DRUG

CeVUS

Contrast enhanced voiding urosonography

Trial Locations (1)

22908-0170

University of Virginia, Charlottesville

All Listed Sponsors
lead

University of Virginia

OTHER

NCT04170413 - Feasibility of Using Contrast Enhanced Voiding Urosonography (CeVUS) During Urodynamic Studies | Biotech Hunter | Biotech Hunter